Roy Golan
CIK: 0001999257
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Golan Roy
Golan Roy (SEC CIK 0001999257) files insider reports with the SEC as Director of NeuroSense Therapeutics Ltd. (NRSN) and Director of My Size, Inc. (MYSZ).
Signal8 holds 3 ownership filings by Golan Roy (2 Form 3, 1 Form 4), filed between Mar 10, 2025 and Mar 18, 2026. Those filings report 1 transaction, the latest on Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Golan Roy's filings is in HERZLIYA.
Recent filings by Golan Roy
- Dec 15, 2025: Grant or award of MYSZ shares (Form 4, code A).
Other insiders filing for NeuroSense Therapeutics Ltd. (NRSN)
- Eisenberg Or, Chief Financial Officer
- Ben-Noon Alon, Chief Executive Officer
- Russek-Blum Niva, Chief Technology Officer
- Binder Hagit, General Manager
- Pellizzari Christine A, Director
- Tracik Ferenc, Chief Medical Officer